We conduct pharmacokinetic and pharmacodynamic studies to evaluate drug exposure, biological activity, and response relationships. Our unit supports intensive sampling schedules and biomarker-driven designs in healthy volunteers and patient populations. Integrated PK/PD data enable informed decisions on dose selection, frequency, and therapeutic potential. These studies help sponsors understand mechanism of action and optimize development strategies early..
Ethics Committee approval for all studies
Medical supervision by experienced clinical staff
Clear participant information and informed consent
Conducted in compliance with ICH-GCP and EU regulations
